Six compounds make up the active range. Each has its own page setting out the research background, the pathways under investigation and its current regulatory status.
Investigational triple agonist acting at the GLP-1, GIP and glucagon receptors.
£150 · 40mg
Three-peptide research blend combining GHK-Cu with BPC-157 and TB-500.
£130 · 70mg — GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg
The GLOW combination with KPV added, supplied as a four-peptide research blend.
£130 · 80mg — GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg
Two-peptide research blend pairing BPC-157 with TB-500 in a single pen.
£130 · 20mg — BPC-157 10mg + TB-500 10mg
Mitochondrial-derived peptide studied in cellular energy and metabolic research.
£130 · 40mg
Cyclic lactam analogue of α-MSH, studied as a non-selective melanocortin receptor agonist.
£80 · specification to be confirmed
Prices exclude delivery. To see the catalogue with card artwork and live stock, visit the main catalogue or the price list.
This product is supplied strictly for in-vitro laboratory research. It is not a medicine, is not licensed by the MHRA, and is not for human or veterinary consumption or administration. We do not supply dosing, reconstitution or administration guidance, and nothing on this page is a therapeutic claim.